MetLife Investment Management’s CareTrust REIT CTRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10M Buy
248,705
+14,034
+6% +$551K 0.05% 381
2026
Q1
$8.6M Buy
234,671
+104,640
+80% +$4.02M 0.04% 403
2025
Q4
$4.7M Sell
130,031
-147
-0.1% -$5.27K 0.02% 654
2025
Q3
$4.51M Buy
130,178
+12,100
+10% +$398K 0.02% 682
2025
Q2
$3.61M Buy
118,078
+3,078
+3% +$88.8K 0.02% 716
2025
Q1
$3.29M Sell
115,000
-1,827
-2% -$49.1K 0.02% 820
2024
Q4
$3.16M Buy
116,827
+31,158
+36% +$931K 0.02% 809
2024
Q3
$2.64M Buy
85,669
+3,156
+4% +$89.3K 0.02% 875
2024
Q2
$2.07M Buy
82,513
+21,244
+35% +$526K 0.01% 950
2024
Q1
$1.49M Buy
61,269
+8,841
+17% +$200K 0.01% 1079
2023
Q4
$1.17M Hold
52,428
– – 0.01% 1219
2023
Q3
$1.07M Hold
52,428
– – 0.01% 1190
2023
Q2
$1.04M Buy
52,428
+1,022
+2% +$20K 0.01% 1249
2023
Q1
$1.01M Hold
51,406
– – 0.01% 1221
2022
Q4
$955K Hold
51,406
– – 0.01% 1237
2022
Q3
$931K Buy
51,406
+983
+2% +$20K 0.01% 1225
2022
Q2
$930K Sell
50,423
-1,863
-4% -$33K 0.01% 1246
2022
Q1
$1.01M Buy
52,286
+19,120
+58% +$377K 0.01% 1315
2021
Q4
$757K Sell
33,166
-3,941
-11% -$83.5K 0.01% 1260
2021
Q3
$754K Hold
37,107
– – 0.01% 1275
2021
Q2
$862K Hold
37,107
– – 0.01% 1255
2021
Q1
$864K Sell
37,107
-5,670
-13% -$130K 0.01% 1228
2020
Q4
$949K Hold
42,777
– – 0.01% 1162
2020
Q3
$761K Hold
42,777
– – 0.01% 1164
2020
Q2
$734K Hold
42,777
– – 0.01% 1172
2020
Q1
$633K Hold
42,777
– – 0.01% 1090
2019
Q4
$882K Hold
42,777
– – 0.01% 1156
2019
Q3
$1.01M Hold
42,777
– – 0.01% 1066
2019
Q2
$1.02M Sell
42,777
-67,527
-61% -$1.64M 0.01% 1095
2019
Q1
$2.59M Buy
110,304
+73,536
+200% +$1.61M 0.01% 1118
2018
Q4
$679K Buy
36,768
+2,665
+8% +$49.6K 0.01% 1187
2018
Q3
$604K Hold
34,103
– – 0.01% 1414
2018
Q2
$569K Hold
34,103
– – 0.01% 1333
2018
Q1
$457K Hold
34,103
– – 0.01% 1423
2017
Q4
$572K Buy
+34,103
New +$630K 0.01% 1328

Other funds holding CTRE

MetLife Investment Management's CTRE Position: Q2 2026 in Review

MetLife Investment Management increased its CareTrust REIT (CTRE) stake by 6% in Q2 2026, buying an estimated $551K and bringing the position to 248,705 shares worth $10M. The position accounts for 0.05% of the portfolio, ranked #381.

MetLife Investment Management first reported a position in CTRE in Q4 2017 and has held it in 35 quarters since. 518 funds tracked by Wall St. Rank hold CTRE as of Q2 2026.

  • MetLife Investment Management held 248,705 shares of CareTrust REIT worth $10M as of Q2 2026.
  • MetLife Investment Management bought 14,034 CareTrust REIT shares in Q2 2026, an estimated $551K.
  • CareTrust REIT made up 0.05% of MetLife Investment Management's portfolio in Q2 2026, its #381 holding.
  • MetLife Investment Management first reported a position in CareTrust REIT in Q4 2017 and has held it in 35 quarters since.
  • 518 funds tracked by Wall St. Rank held CareTrust REIT as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.